Clinical Trial Update: Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the efficacy and safety of MUSKARDIA (Shexiang Baoxin Pill) in acute myocardial infarction, including patients undergoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• MUSKARDIA (Shexiang Baoxin Pill)

Snippet

Sponsor: Shanghai Hutchison Pharmaceuticals Limited | Conditions: Acute Myocardial Infarction (AMI), Percutaneous Coronary Intervention (PCI) | Phase 4 | Status: NOT_YET_RECRUITING